ATPC vs PBH vs PRGO Stock Comparison

Agape ATP, Prestige Consumer Healthcare and Perrigo Prices as of Nov 13, 2026 Peers: Industry group
ATPC Agape ATP Corp
$1.27 -27.8% 1M -98.2% 1Y
Market cap
$64.01M
P/E
–
Revenue (TTM)
$1.06M
Div. yield
–
Personal Care Products Consumer Staples
PRGO PERRIGO Co plc
$16.26 +1.9% 1M +16.4% 1Y
Market cap
$2.26B
P/E
–
Revenue (TTM)
$4.09B
Div. yield
–
Personal Care Products Consumer Staples
3 wins

Head to Head

10 decided of 12

Prestige Consumer Healthcare leads on 7 of the 12 questions below (Prestige Consumer Healthcare 7, Perrigo 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionATPCPBHPRGOLeader
Larger companyMarket capitalisation $64.01M $2.27B $2.26B PBH
Cheaper on earningsLower P/E, profitable companies only -55.4x 14.6x -1.3x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 9.6x 6.7x PRGO
Faster revenue growthRevenue growth, trailing twelve months -26.9% +5.1% -4.5% PBH
More profitableNet margin, trailing twelve months -109.3% 13.3% -43.3% PBH
Better return on capitalReturn on invested capital — 5.3% -27.9% PBH
Less leveragedLower net debt / EBITDA — 6.1x -2.2x PRGO
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -98.2% -23.1% +16.4% PRGO
Better 5-year returnAnnualised price return, 5 years — -6.0%/yr -17.8%/yr PBH
Less volatileAnnualised volatility, 1 year 375.9% 39.1% 49.6% PBH
Higher overall scoreMean of the five percentile scores vs peers 42/100 66/100 43/100 PBH

Percentile Scorecard

ATPCPBHPRGO

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisATPCPBHPRGO
Valuation 15 #47 of 55 89 #7 of 55 57 #24 of 55
Growth 45 #29 of 52 65 #19 of 52 6 #49 of 52
Profitability 29 #36 of 50 74 #14 of 50 27 #37 of 50
Financial Health 78 #14 of 59 36 #38 of 59 29 #42 of 59
Shareholder Returns – 65 #12 of 32 94 #3 of 32
Overall 42 66 43
  • ATPC ranked among 60 companies in Household and Personal Products
  • PBH ranked among 60 companies in Household and Personal Products
  • PRGO ranked among 60 companies in Household and Personal Products

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodATPCPBHPRGOSPY
1 month -27.8%-4.6%+1.9% -2.0%
3 months -49.0%-10.2%+24.7% -2.8%
6 months -42.5%-1.3%+53.3% +2.0%
Year to date -76.3%-25.2%+16.8% +10.6%
1 year -98.2%-23.1%+16.4% +12.2%
3 years -99.9%-22.4%-43.7% +68.1%
3 years, per year -88.8%-8.1%-17.4% +18.9%
5 years —-26.4%-62.4% +61.4%
5 years, per year —-6.0%-17.8% +10.1%
10 years —-7.1%-81.8% +248.5%
10 years, per year —-0.7%-15.7% +13.3%

Risk

MeasureATPCPBHPRGOSPY
Volatility, 1Y 375.9%39.1%49.6% 13.6%
Downside volatility, 1Y 422.5%47.0%43.6% 13.9%
Beta vs S&P 500, 1Y -0.550.431.02 1.00
Return / volatility, 1Y -0.26-0.590.33 0.90
Max drawdown, 5Y -100.0%-51.8%-78.5% -25.4%
From 52-week high -98.2%-34.3%-4.1% -3.2%
52-week high $69.00$70.21$16.96 $779.14
52-week low $1.24$42.94$9.25 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleATPCPBHPRGO
P/E now vs peer median -55.0xmedian 21.1x 14.1xmedian 21.1x -1.3xmedian 21.1x
P/S now vs peer median 60.1xmedian 2.2x 1.9xmedian 2.2x 0.6xmedian 2.2x
EV/EBITDA now vs peer median -20.6xmedian 14.0x 12.8xmedian 14.0x -3.9xmedian 14.0x
P/FCF now vs peer median -65.4xmedian 17.3x 10.2xmedian 17.3x 13.4xmedian 17.3x
P/B now vs peer median 2.9xmedian 1.9x 1.1xmedian 1.9x 0.9xmedian 1.9x
PEG now vs peer median 1.58median 0.87 0.24median 0.87 0.00median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsATPCPBHPRGO
Revenue $1.06M $1.17B $4.09B
Gross profit $644.22K $612.39M $1.32B
Operating income -$3.13M $291.22M -$1.61B
Net income -$1.16M $155.10M -$1.77B
Free cash flow -$970.57K $214.22M $168.20M
R&D – – $92.00M
EPS (diluted) $-1.15 $3.26 $-12.70
Cash & equivalents $89.65K $46.52M $436.60M
Total debt – $2.08B $3.29B
Shares (diluted) 1.00M 47.59M 139.40M
Enterprise value $63.42M $2.01B $538.76M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricATPCPBHPRGO
P/E -55.0x 14.1x -1.3x
P/FCF -65.4x 10.2x 13.4x
P/Operating cash flow -65.5x 9.5x 9.4x
P/S 60.1x 1.9x 0.6x
P/B 2.9x 1.1x 0.9x
P/Tangible book 2.9x -1.5x 7.5x
EV/EBITDA -20.6x 12.8x -3.9x
EV/EBIT -20.3x 14.5x -3.2x
EV/Revenue 60.0x 3.6x 1.3x
EV/FCF -65.3x 19.7x 30.4x
EV/Operating cash flow -65.4x 18.4x 21.3x
PEG (3Y EPS CAGR) 1.58 0.24 0.00

Growth

14 metrics
MetricATPCPBHPRGO
Revenue growth (1Y) -26.9% 5.1% -4.5%
Revenue CAGR (3Y) -15.2% 1.2% -4.2%
Gross profit growth (1Y) -11.4% -1.7% -12.9%
Gross profit CAGR (3Y) -14.1% -0.3% -6.8%
Operating income growth (1Y) -13.6% -12.2% -677.9%
Operating income CAGR (3Y) -20.9% 153.5% -116.4%
Net income growth (1Y) 56.7% -22.8% -3,316%
Net income CAGR (3Y) 13.2% 57.4% -655.7%
EPS growth (1Y) 56.5% -20.1% -3,304%
EPS CAGR (3Y) -34.8% 58.7% -651.2%
Operating cash flow growth (1Y) 67.9% -12.8% -36.0%
Operating cash flow CAGR (3Y) 2.9% 0.8% -14.3%
Free cash flow growth (1Y) 68.3% -16.1% -38.0%
Free cash flow CAGR (3Y) 3.3% -0.2% -16.8%

Profitability

14 metrics
MetricATPCPBHPRGO
Gross margin 60.9% 52.5% 32.3%
EBITDA margin -290.9% 28.4% -31.8%
Operating margin -295.9% 25.0% -39.4%
Pretax margin -116.0% 18.2% -40.4%
Net margin -109.3% 13.3% -43.3%
FCF margin -91.8% 18.4% 4.1%
Operating cash flow margin -91.8% 19.7% 5.9%
Return on equity -5.2% 8.2% -71.4%
Return on assets -4.6% 3.4% -23.4%
Return on invested capital – 5.3% -27.9%
Return on capital employed -14.2% 6.5% -24.7%
Asset turnover 0.0x 0.3x 0.5x
Cash conversion (OCF / net income) 0.8x 1.5x -0.1x
Stock comp / revenue – 0.9% 1.1%

Financial Health

11 metrics
MetricATPCPBHPRGO
Debt / assets – 44.0% 44.0%
Debt / equity – 1.1x 1.3x
Net debt / EBITDA – 6.1x -2.2x
Debt / FCF – 9.7x 19.6x
Liabilities / assets 11.9% 58.8% 67.4%
Equity / assets 88.1% 41.2% 32.6%
Interest coverage – 4.4x –
Current ratio 8.4x 2.9x 2.4x
Quick ratio 0.0x 1.7x 1.1x
Cash ratio 0.0x 0.3x 0.4x
Altman Z-score 12.82 1.54 -0.43

Shareholder Returns

7 metrics
MetricATPCPBHPRGO
Dividend yield – – 7.1%
Net buyback yield – 2.1% –
Shareholder yield – 2.1% 7.1%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusATPCPBHPRGO
Forward P/E – 9.6xFY2026 6.7xFY2026
EPS, next fiscal year – $4.79FY2026 $2.44FY2026
EPS growth, next FY – +9.4%FY2026 -11.3%FY2026
EPS growth, the year after – -0.4% -9.0%
Revenue, next fiscal year – $1.23BFY2026 $4.15BFY2026
Revenue growth, next FY – +13.2%FY2026 -2.4%FY2026
Revenue growth, the year after – +16.9% -3.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersATPCPBHPRGO
Held by institutions – 100.0% 100.0%
Institutions holding – 319 340
Change in shares held, QoQ – +3.4% +6.4%
Institutions buying – 156 195
Institutions selling – 123 92
Buyers to sellers – 1.27 2.12

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ATPCPBHPRGO
ATPC 1.00 -0.03 0.01
PBH -0.03 1.00 0.34
PRGO 0.01 0.34 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ATPC, PBH and PRGO?

Prestige Consumer Healthcare (PBH) is the largest by market capitalisation: Agape ATP (ATPC) $64.01M, Prestige Consumer Healthcare (PBH) $2.27B, Perrigo (PRGO) $2.26B.

Which company is growing faster?

Prestige Consumer Healthcare (PBH) grew revenue fastest over the trailing twelve months: Agape ATP (ATPC) -26.9%, Prestige Consumer Healthcare (PBH) +5.1%, Perrigo (PRGO) -4.5%.

Which company is more profitable?

Prestige Consumer Healthcare (PBH) has the highest net margin (Agape ATP (ATPC) -109.3%, Prestige Consumer Healthcare (PBH) 13.3%, Perrigo (PRGO) -43.3%). On return on invested capital, Prestige Consumer Healthcare (PBH) leads (Prestige Consumer Healthcare (PBH) 5.3%, Perrigo (PRGO) -27.9%).

Which stock has performed better?

Over the past year Perrigo (PRGO) returned the most: Agape ATP (ATPC) -98.2%, Prestige Consumer Healthcare (PBH) -23.1%, Perrigo (PRGO) +16.4%. Over five years, Prestige Consumer Healthcare (PBH) compounded fastest (Prestige Consumer Healthcare (PBH) -6.0%/yr, Perrigo (PRGO) -17.8%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Prestige Consumer Healthcare (PBH) has been the steadiest (Agape ATP (ATPC) 375.9%, Prestige Consumer Healthcare (PBH) 39.1%, Perrigo (PRGO) 49.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ATPC, PBH and PRGO?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Prestige Consumer Healthcare (PBH) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.